Portugal, April 30 -- Portugal based FRESENIUS KABI PHARMA PORTUGAL has secured contract from Unidade Local De Saude De Santa Maria, E. P. E. for Invitation To The Presentation Of Proposals Under The Agreement (S) - Framework 2023/304 - Group 4: Blood Medicines; 2023/491 - Cancer And Immunomodulators And 2023/492 - Medicine. The value of the contract is worth 4309230 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....